Verastem, Inc. (VSTM)
6.85
-0.04
(-0.58%)
USD |
NASDAQ |
Aug 24, 16:00
6.85
0.00 (0.00%)
After-Hours: 20:00
Verastem Price : 6.85 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 6.88 | 7.02 | 6.784 | 6.89 | 996115.0 |
| Aug 20, 2026 | 7.25 | 7.43 | 6.63 | 6.82 | 2.294M |
| Aug 19, 2026 | 7.65 | 7.86 | 7.20 | 7.295 | 2.372M |
| Aug 18, 2026 | 7.18 | 7.678 | 7.18 | 7.43 | 2.924M |
| Aug 17, 2026 | 6.52 | 7.195 | 6.45 | 7.18 | 2.284M |
| Aug 14, 2026 | 6.66 | 6.66 | 6.44 | 6.58 | 1.280M |
| Aug 13, 2026 | 7.06 | 7.06 | 6.64 | 6.67 | 1.857M |
| Aug 12, 2026 | 7.01 | 7.101 | 6.890 | 6.95 | 1.264M |
| Aug 11, 2026 | 6.71 | 7.179 | 6.624 | 7.05 | 2.088M |
| Aug 10, 2026 | 6.67 | 6.835 | 6.34 | 6.79 | 2.298M |
| Aug 07, 2026 | 6.65 | 7.10 | 6.02 | 6.74 | 4.319M |
| Aug 06, 2026 | 5.91 | 6.00 | 5.73 | 5.91 | 2.189M |
| Aug 05, 2026 | 5.88 | 5.971 | 5.775 | 5.87 | 1.555M |
| Aug 04, 2026 | 5.64 | 5.89 | 5.64 | 5.81 | 1.792M |
| Aug 03, 2026 | 5.81 | 5.845 | 5.58 | 5.69 | 1.288M |
| Jul 31, 2026 | 6.04 | 6.09 | 5.54 | 5.80 | 1.857M |
| Jul 30, 2026 | 5.92 | 6.165 | 5.705 | 6.10 | 1.452M |
| Jul 29, 2026 | 6.24 | 6.31 | 5.82 | 6.01 | 2.250M |
| Jul 28, 2026 | 6.06 | 6.25 | 5.945 | 6.23 | 1.275M |
| Jul 27, 2026 | 6.17 | 6.464 | 6.065 | 6.08 | 2.244M |
| Jul 24, 2026 | 6.20 | 6.25 | 5.845 | 6.05 | 2.532M |
| Jul 23, 2026 | 5.87 | 6.305 | 5.75 | 6.18 | 2.194M |
| Jul 22, 2026 | 6.01 | 6.110 | 5.745 | 5.89 | 1.343M |
| Jul 21, 2026 | 5.70 | 6.10 | 5.70 | 6.00 | 2.532M |
| Jul 20, 2026 | 6.04 | 6.215 | 5.71 | 5.75 | 2.533M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 29.63 |
| Ironwood Pharmaceuticals, Inc. | 4.125 |
| Dianthus Therapeutics, Inc. | 110.08 |
| Alnylam Pharmaceuticals, Inc. | 236.06 |
| Anika Therapeutics, Inc. | 21.31 |
Price Related Metrics
| PS Ratio | 6.945 |
| Price to Book Value | 12.40 |
| Earnings Yield | -35.91% |
| Market Cap | 619.80M |